$130.31
1.65% yesterday
NYSE, Sep 12, 10:00 pm CET
ISIN
US8793691069
Symbol
TFX

Teleflex Incorporated Stock price

$130.31
+10.67 8.92% 1M
-5.21 3.84% 6M
-47.67 26.78% YTD
-112.42 46.31% 1Y
-114.84 46.84% 3Y
-241.57 64.96% 5Y
-5.97 4.38% 10Y
+59.16 83.15% 20Y
NYSE, Closing price Fri, Sep 12 2025
-2.19 1.65%

Key metrics

Basic
Market capitalization
$5.9b
Enterprise Value
$7.5b
Net debt
$1.6b
Cash
$253.7m
Shares outstanding
44.2m
Valuation (TTM | estimate)
P/E
30.7 | 9.3
P/S
1.9 | 1.7
EV/Sales
2.5 | 2.2
EV/FCF
18.9
P/B
1.4
Dividends
DPS
$1.36
Yield 1Y | 5Y
1.0% | 0.5%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
91.3% | 24.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$3.0b | $3.4b
EBITDA
$866.3m | $901.2m
EBIT
$592.8m | $807.5m
Net Income
$191.9m | $627.2m
Free Cash Flow
$396.4m
Growth (TTM | estimate)
Revenue
1.1% | 10.2%
EBITDA
6.0% | 9.9%
EBIT
5.6% | 48.0%
Net Income
-27.2% | 800.1%
Free Cash Flow
-5.0%
Margin (TTM | estimate)
Gross
55.6%
EBITDA
28.5% | 26.8%
EBIT
19.5%
Net
6.3% | 18.7%
Free Cash Flow
13.0%
Financial Health
Equity Ratio
60.3%
Return on Equity
1.6%
ROCE
8.9%
ROIC
6.8%
Debt/Equity
0.4
More
EPS
$4.3
FCF per Share
$9.0
Short interest
3.4%
Employees
14k
Rev per Employee
$220.0k
Show more

Is Teleflex Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Teleflex Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Teleflex Incorporated forecast:

1x Buy
5%
14x Hold
67%
6x Sell
29%

Analyst Opinions

21 Analysts have issued a Teleflex Incorporated forecast:

Buy
5%
Hold
67%
Sell
29%

Financial data from Teleflex Incorporated

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3,041 3,041
1% 1%
100%
- Direct Costs 1,351 1,351
2% 2%
44%
1,691 1,691
1% 1%
56%
- Selling and Administrative Expenses 940 940
3% 3%
31%
- Research and Development Expense 158 158
4% 4%
5%
866 866
6% 6%
28%
- Depreciation and Amortization 273 273
7% 7%
9%
EBIT (Operating Income) EBIT 593 593
6% 6%
19%
Net Profit 192 192
27% 27%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Teleflex Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Teleflex Incorporated Stock News

Neutral
GlobeNewsWire
one day ago
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents
Neutral
Seeking Alpha
2 days ago
Teleflex Incorporated (NYSE:TFX ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 3:20 PM EDT Company Participants Liam Kelly - Chairman, President & CEO Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Research All right. Let's kick it off.
Neutral
GlobeNewsWire
18 days ago
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. (ET).
More Teleflex Incorporated News

Company Profile

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.

Head office United States
CEO Liam Kelly
Employees 14,100
Founded 1943
Website www.teleflex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today